David R. Langley

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

Min Gao, Richard E. Nettles, Makonen Belema et al. · Nature · 2010 · 929 citations · Full text

Hcv Ns5a Inhibitor, Viral Hepatitis, Medicine +10

Selective Interactions of Cationic Porphyrins with G-Quadruplex Structures

Haiyong Han, David R. Langley, Anupama Rangan et al. · Journal of the American Chemical Society · 2001 · 318 citations

Inhibition of Hepatitis B Virus Polymerase by Entecavir

David R. Langley, Ann W. Walsh, Carl J. Baldick et al. · Journal of Virology · 2007 · 187 citations · Full text

Viral Replication, Biochemistry, Viral Hepatitis +15

Biochemical and Genetic Characterizations of a Novel Human Immunodeficiency Virus Type 1 Inhibitor That Blocks gp120-CD4 Interactions

Qi Guo, Hsu‐Tso Ho, Ira B. Dicker et al. · Journal of Virology · 2003 · 167 citations · Full text

Immunology, Molecular Biology, Bms-378806 Binds +17

Pyrrolo[1,4]benzodiazepine antitumor antibiotics: relationship of DNA alkylation and sequence specificity to the biological activity of natural and synthetic compounds

Laurence H. Hurley, Teri Reck, David E. Thurston et al. · Chemical Research in Toxicology · 1988 · 139 citations